FemBloc® Permanent Contraception - Confirmation Feasibility Trial
NCT ID: NCT04273594
Last Updated: 2025-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
45 participants
INTERVENTIONAL
2020-02-27
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Allis Clamp Versus Single-tooth Tenaculum
NCT05187078
Pilot Study of Suction as a Mechanism of IUD Expulsion With Concomitant Menstrual Cup Use
NCT05254041
Pilot Removal of Palpable Subdermal Contraceptive Rod Implants
NCT03356119
A Confirmatory Study Confirming Performance of a New Intermittent Catheter
NCT05485935
Removal of Palpable Subdermal Contraceptive Rod Implants.
NCT02986971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FemBloc
Investigational device and procedure
FemBloc
Treatment with FemBloc for women who desire permanent birth control (female sterilization)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FemBloc
Treatment with FemBloc for women who desire permanent birth control (female sterilization)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sexually active with male partner
* Regular menstrual cycle for last 3 months or on hormonal contraceptives
Exclusion Criteria
* Known or suspected pregnancy
* Prior tubal surgery, including sterilization attempt
* Prior endometrial ablation
* Presence, suspicion, or previous history of gynecologic malignancy
* Abnormal uterine bleeding requiring evaluation or treatment
* Scheduled to undergo concomitant intrauterine procedures at the time of procedure(s)
* Allergy to shellfish, betadine or iodinated contrast
21 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Femasys Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New Horizons Clinical Trials
Chandler, Arizona, United States
Precision Trials AZ, LLC
Phoenix, Arizona, United States
Midtown OB GYN North
Columbus, Georgia, United States
Women's Health Advantage
Fort Wayne, Indiana, United States
Saginaw Valley Medical Research Group
Saginaw, Michigan, United States
University Hospitals - Cleveland Medical Center
Beachwood, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-100-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.